Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Wei, Yao ^a   Zhu, Weiming ^a   Gong, Jianfeng ^a   Guo, Dong ^a   Gu, Lili ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CROHN DISEASE; DISEASE ACTIVITY; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; PATIENT ATTITUDE; QUALITY OF LIFE; QUESTIONNAIRE; TRANSPLANTATION; ULCERATIVE COLITIS;

EID: 84934916639     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/517597     Document Type: Article

References (14)

1. C. Hedin, K. Whelan, and J. O. Lindsay, "Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials," Proceedings of the Nutrition Society, vol. 66, no. 03, pp. 307-315, 2007
2. N. A. Nagalingam and S. V. Lynch, "Role of the microbiota in inflammatory bowel diseases," Inflammatory Bowel Diseases, vol. 18, no. 5, pp. 968-984, 2012
3. A. Moradkhani, L. J. Beckman, and J. H. Tabibian, "Healthrelated quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors," Journal of Crohn's and Colitis, vol. 7, no. 6, pp. 467-473, 2013
4. N. J. Talley, M. T. Abreu, J.-P. Achkar et al., "An evidence-based systematic review on medical therapies for inflammatory bowel disease,"The American Journal of Gastroenterology, vol. 106, no. 1, pp. S2-S25, 2011
5. J. L. Anderson, R. J. Edney, and K. Whelan, "Systematic review: faecal microbiota transplantation in themanagement of inflammatory bowel disease," Alimentary Pharmacology & Therapeutics, vol. 36, no. 6, pp. 503-516, 2012
6. S. Kunde, A. Pham, S. Bonczyk et al., "Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis," Journal of Pediatric Gastroenterology and Nutrition, vol. 56, no. 6, pp. 597-601, 2013
7. E. van Nood, A. Vrieze, M. Nieuwdorp et al., "Duodenal infusion of donor feces for recurrent clostridium difficile," The New England Journal of Medicine, vol. 368, no. 5, pp. 407-415, 2013
8. S. C. Ng, S. Plamondon, A. Gupta, D. Burling, andM.A. Kamm, "Prospective assessment of the effect on quality of life of antitumour necrosis factor therapy for perineal Crohn's fistulas," Alimentary Pharmacology and Therapeutics, vol. 30, no. 7, pp. 757-766, 2009
9. P. K. Kump, H.-P. Grochenig, S. Lackner et al., "Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis," Inflammatory Bowel Diseases, vol. 19, no. 10, pp. 2155-2165, 2013
10. I. Cho and M. J. Blaser, "The human microbiome: at the interface of health and disease," Nature Reviews Genetics, vol. 13, pp. 260-270, 2012
11. L. P. Smits, K. E. C. Bouter, W. M. de Vos, T. J. Borody, and M. Nieuwdorp, "Therapeutic potential of fecal microbiota transplantation," Gastroenterology, vol. 145, no. 5, pp. 946-953, 2013
12. O. C. Aroniadis and L. J. Brandt, "Fecal microbiota transplantation: past, present and future," Current Opinion in Gastroenterology, vol. 29, no. 1, pp. 79-84, 2013
13. A. Sainsbury and R. V. Heatley, "Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease," Alimentary Pharmacology andTherapeutics, vol. 21, no. 5, pp. 499-508, 2005
14. S. A. Kahn, R. Gorawara-Bhat, and D. T. Rubin, "Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?" Inflammatory Bowel Diseases, vol. 18, no. 4, pp. 676-684, 2012